Samil Pharmaceutical Co.,Ltd (KRX: 000520)
South Korea
· Delayed Price · Currency is KRW 13,450
+110 (0.82%)
Nov 15, 2024, 3:30 PM KST
Samil Pharmaceutical Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 210,733 | 196,346 | 179,676 | 134,247 | 122,999 | 121,107 | Upgrade
|
| Other Revenue | - | - | -0 | - | -0 | 0 | Upgrade
|
| Revenue | 210,733 | 196,346 | 179,676 | 134,247 | 122,999 | 121,107 | Upgrade
|
| Revenue Growth (YoY) | 15.12% | 9.28% | 33.84% | 9.14% | 1.56% | 28.02% | Upgrade
|
| Cost of Revenue | 131,940 | 122,275 | 112,191 | 85,259 | 73,967 | 74,383 | Upgrade
|
| Gross Profit | 78,793 | 74,071 | 67,486 | 48,988 | 49,032 | 46,724 | Upgrade
|
| Selling, General & Admin | 65,449 | 61,138 | 57,746 | 43,287 | 37,647 | 37,733 | Upgrade
|
| Research & Development | 5,913 | 5,601 | 2,907 | 2,971 | 3,007 | 3,060 | Upgrade
|
| Other Operating Expenses | 545.45 | 516.12 | 637.98 | 623.15 | 594.91 | 487.51 | Upgrade
|
| Operating Expenses | 72,531 | 67,611 | 63,469 | 48,589 | 42,494 | 41,928 | Upgrade
|
| Operating Income | 6,262 | 6,460 | 4,017 | 399.74 | 6,538 | 4,796 | Upgrade
|
| Interest Expense | -2,633 | -3,545 | -4,263 | -6,202 | -5,505 | -3,903 | Upgrade
|
| Interest & Investment Income | 59.78 | 34.72 | 70.02 | 129.99 | 164.07 | 207.4 | Upgrade
|
| Earnings From Equity Investments | 0.43 | 0.49 | 122.8 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -290.98 | -277.57 | 197.76 | 246.09 | -155.19 | 33.38 | Upgrade
|
| Other Non Operating Income (Expenses) | 21.46 | -2,367 | 580.12 | 299.46 | 183.71 | 303.75 | Upgrade
|
| EBT Excluding Unusual Items | 3,420 | 306.5 | 724.39 | -5,127 | 1,226 | 1,438 | Upgrade
|
| Gain (Loss) on Sale of Investments | -585 | -585 | -7.11 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 36.83 | 1,702 | 340.82 | 365.84 | -27.53 | 17.68 | Upgrade
|
| Pretax Income | 2,871 | 1,424 | 1,058 | -4,761 | 1,198 | 1,456 | Upgrade
|
| Income Tax Expense | 4,027 | -239.76 | 1,086 | 585.31 | -142.5 | 669.35 | Upgrade
|
| Net Income | -1,155 | 1,664 | -28.29 | -5,347 | 1,341 | 786.26 | Upgrade
|
| Net Income to Common | -1,155 | 1,664 | -28.29 | -5,347 | 1,341 | 786.26 | Upgrade
|
| Net Income Growth | - | - | - | - | 70.50% | - | Upgrade
|
| Shares Outstanding (Basic) | 15 | 14 | 14 | 14 | 13 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 14 | 14 | 14 | 13 | 13 | Upgrade
|
| Shares Change (YoY) | -6.94% | 3.42% | 0.82% | 2.85% | 0.13% | 15.56% | Upgrade
|
| EPS (Basic) | -74.70 | 116.16 | -2.03 | -386.63 | 99.70 | 58.55 | Upgrade
|
| EPS (Diluted) | -74.70 | 115.00 | -2.03 | -386.63 | 99.70 | 58.55 | Upgrade
|
| EPS Growth | - | - | - | - | 70.28% | - | Upgrade
|
| Free Cash Flow | -7,740 | -12,498 | -44,327 | -31,411 | -9,245 | -3,300 | Upgrade
|
| Free Cash Flow Per Share | -500.50 | -866.82 | -3179.29 | -2271.39 | -687.53 | -245.75 | Upgrade
|
| Dividend Per Share | - | - | - | - | 68.182 | 68.182 | Upgrade
|
| Dividend Growth | - | - | - | - | 0% | 50.00% | Upgrade
|
| Gross Margin | 37.39% | 37.72% | 37.56% | 36.49% | 39.86% | 38.58% | Upgrade
|
| Operating Margin | 2.97% | 3.29% | 2.24% | 0.30% | 5.32% | 3.96% | Upgrade
|
| Profit Margin | -0.55% | 0.85% | -0.02% | -3.98% | 1.09% | 0.65% | Upgrade
|
| Free Cash Flow Margin | -3.67% | -6.37% | -24.67% | -23.40% | -7.52% | -2.73% | Upgrade
|
| EBITDA | 11,691 | 11,828 | 9,006 | 5,112 | 10,738 | 8,812 | Upgrade
|
| EBITDA Margin | 5.55% | 6.02% | 5.01% | 3.81% | 8.73% | 7.28% | Upgrade
|
| D&A For EBITDA | 5,429 | 5,368 | 4,989 | 4,712 | 4,199 | 4,016 | Upgrade
|
| EBIT | 6,262 | 6,460 | 4,017 | 399.74 | 6,538 | 4,796 | Upgrade
|
| EBIT Margin | 2.97% | 3.29% | 2.24% | 0.30% | 5.32% | 3.96% | Upgrade
|
| Effective Tax Rate | 140.23% | - | 102.67% | - | - | 45.98% | Upgrade
|
| Advertising Expenses | - | 8,699 | 11,389 | 7,674 | 6,187 | 5,664 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.